Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

CRT-D

CRT-D associated with major improvements among older HFrEF patients

The study's authors said CRT use among older patients represents a "major gap in knowledge." 

The Vektor Medical vMap system takes standard 12-lead ECGs and converts them into detailed electro anatomical maps for us in catheter ablation procedures.

Electrophysiologists debut new technology that builds interactive cardiac maps out of 12-lead ECGs

The solution, which gained FDA clearance in November 2021, is now being used by specialists at the University of California San Diego Health.

The Freezor Cardiac Cryoablation Catheters

FDA expands two Medtronic cardiac cryoablation catheters for AVNRT

The two single-use devices are now approved for the treatment of pediatric AVNRT.

A dedicated Cardiac MRI scanner. The presence of myocardial fibrosis on cardiac MRI can help anticipate adverse arrhythmic events and  may offer a way to improve patient selection for cardiac implantable electronic devices (CIEDs). This is a dedicated cardiac MRI system at Baylor Scott White.

Cardiac MRI a powerful tool for predicting sudden cardiac death, arrhythmia after CIED implantation

The study's authors suspect their findings could improve patient selection for CIEDs. 

healthcare value value-based care money dollar

Boston Scientific finalizes acquisition of Baylis Medical with $1.75B payment

The deal, first announced in October 2021, expands Boston Scientific’s structural heart disease and electrophysiology portfolios by a significant margin. 

quality excellence star stethoscope

Enrollment in ACC NCDR increased after U.S. News and World Report said it could improve hospital rankings

Even with this bump, only about one in three eligible hospitals participate in the NCDR registries. 

The Abbott Aveir DR dual-chamber leadless pacemaker recently had its first human implant occur in the Aveir DR i2i study pivotal trial.

First implant of dual-chamber leadless pacemaker completed in Abbott’s Aveir DR i2i pivotal trial

The investigational dual-chamber pacemaker is designed to provide synchronous, beat-by-beat pacing of the right atrium and right ventricle of the heart.

Thumbnail

Philips pledges to help American Heart Association raise awareness about CIED infections

A majority of patients in the United States with CIED infections do not receive proper, guideline-approved care.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup